165 results
Page 3 of 9
8-K
EX-99.1
lxqtx5e9iq253
24 Aug 21
Bio-Path Holdings Announces Clearance of Investigational New Drug Application for BP1002 in Refractory/Relapsed Acute Myeloid Leukemia Patients
8:29am
8-K
o9d 0jdo0lo919z75g4o
23 Apr 21
Bio-Path Announces Publication in Biomedicines
5:25pm
8-K
EX-99.1
5mpibiv1a0
23 Apr 21
Bio-Path Announces Publication in Biomedicines
5:25pm
8-K
EX-99.1
tblacrt0fs8r7y wlej
17 Feb 21
Placement Agency Agreement
5:11pm
8-K
EX-10.1
0inrhf
17 Feb 21
Placement Agency Agreement
5:11pm
8-K
EX-99.1
qf71nvyvgcvjbu2n
19 Nov 20
Bio-Path Holdings Announces First Patient Dosed in Phase 1 Clinical Trial of BP1002
4:30pm
8-K
EX-10.1
sofmn44 om
14 Jul 20
Entry into a Material Definitive Agreement
6:05am
8-K
EX-99.1
svi4ewb4lc sw8
6 Mar 20
Bio-path Holdings Reports Full Year 2019 Financial Results
7:10am